Handelsbanken Fonder AB Acquires 4,394 Shares of HCA Healthcare, Inc. $HCA

Handelsbanken Fonder AB grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.3% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 198,212 shares of the company’s stock after acquiring an additional 4,394 shares during the period. Handelsbanken Fonder AB owned 0.08% of HCA Healthcare worth $75,935,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the stock. Prudential PLC increased its position in shares of HCA Healthcare by 64.3% during the 2nd quarter. Prudential PLC now owns 6,557 shares of the company’s stock worth $2,512,000 after purchasing an additional 2,566 shares during the last quarter. Cumberland Partners Ltd acquired a new position in HCA Healthcare during the second quarter worth $2,299,000. Empirical Finance LLC grew its position in shares of HCA Healthcare by 0.6% in the 2nd quarter. Empirical Finance LLC now owns 7,273 shares of the company’s stock valued at $2,786,000 after acquiring an additional 42 shares during the period. TD Waterhouse Canada Inc. raised its holdings in shares of HCA Healthcare by 3.1% in the 2nd quarter. TD Waterhouse Canada Inc. now owns 14,738 shares of the company’s stock valued at $5,743,000 after purchasing an additional 444 shares during the period. Finally, Investidor Profissional Gestao de Recursos Ltda. grew its holdings in HCA Healthcare by 52.2% during the second quarter. Investidor Profissional Gestao de Recursos Ltda. now owns 6,867 shares of the company’s stock worth $2,631,000 after purchasing an additional 2,354 shares during the period. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Bank of America lifted their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Royal Bank Of Canada lifted their price objective on shares of HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. Cowen reaffirmed a “buy” rating on shares of HCA Healthcare in a report on Monday, October 27th. Wolfe Research downgraded shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Finally, Oppenheimer increased their target price on HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a research note on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $474.53.

HCA Healthcare Stock Down 0.9%

Shares of NYSE:HCA opened at $476.55 on Friday. The firm has a market cap of $108.74 billion, a PE ratio of 18.42, a PEG ratio of 1.38 and a beta of 1.41. The company’s 50 day moving average price is $439.27 and its two-hundred day moving average price is $399.79. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $485.74.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.